Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Cipla
Accenture
QuintilesIMS
Colorcon
Harvard Business School
US Army
Federal Trade Commission
Fish and Richardson

Generated: April 20, 2018

DrugPatentWatch Database Preview

PROCANBID Drug Profile

« Back to Dashboard

Which patents cover Procanbid, and when can generic versions of Procanbid launch?

Procanbid is a drug marketed by King Pharms and is included in one NDA.

The generic ingredient in PROCANBID is procainamide hydrochloride. There are eight drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the procainamide hydrochloride profile page.
Summary for PROCANBID
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 48
Patent Applications: 3,708
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PROCANBID at DailyMed
Drug patent expirations by year for PROCANBID
Medical Subject Heading (MeSH) Categories for PROCANBID
Anti-Arrhythmia Agents
Voltage-Gated Sodium Channel Blockers
Synonyms for PROCANBID
(4-aminophenyl)-N-[2-(diethylamino)ethyl]carboxamide
051P069
2-Diethylaminoethylamid kyseliny p-aminobenzoove
2-Diethylaminoethylamid kyseliny p-aminobenzoove [Czech]
4-{N-[2-(diethylamino)ethyl]carbamoyl}aniline
4-14-00-01154 (Beilstein Handbook Reference)
4-Amino-N-(2-(diethylamino)ethyl)benzamide
4-Amino-N-(2-(Diethylamino)Ethyl)Benzamide Sulfate
4-amino-N-(2-diethylaminoethyl)-benzamide
4-amino-N-(2-diethylaminoethyl)benzamide
4-Amino-N-(diethylaminoethyl)benzamide
4-Amino-N-[2-(diethylamino)ethyl]benzamide
4-Amino-N-[2-(diethylamino)ethyl]benzamide #
4-amino-N-[2-(diethylamino)ethyl]benzamide;hydrochloride
4-azanyl-N-[2-(diethylamino)ethyl]benzamide;hydrochloride
4CH-025189
51-06-9
614-39-1 (hydrochloride)
7077AB
AB00053530
AB00053530_16
AB00053530-13
AB00053530-15
AC1L1J8A
AC1Q2ZC8
AC1Q2ZC9
AC1Q2ZCA
ACM51069
AJ-26690
AK-41140
AKOS000271131
API0005839
ARONIS023727
AX8170933
BB 0216450
BB0265863
BBB/768
BBL023442
BDBM39344
Benzamide, 4-amino-N-(2-(diethylamino)ethyl)-
Benzamide, 4-amino-N-(2-(diethylamino)ethyl)- (9CI)
Benzamide, 4-amino-N-(2-(diethylamino)ethyl)-(9CI)
Benzamide, 4-amino-N-[2-(diethylamino)ethyl]-
Benzamide, p-amino-N-(2-(diethylamino)ethyl)-
Benzamide, p-amino-N-[2-(diethylamino)ethyl]-
BIDD:GT0579
Bio1_000391
Bio1_000880
Bio1_001369
Bio2_000183
Bio2_000663
Biocoryl
BPBio1_000411
BRD-K75089421-001-02-5
BRD-K75089421-003-04-7
BRD-K75089421-003-05-4
BRN 2214285
BSPBio_000373
BSPBio_001463
BSPBio_002229
C07401
Cambridge id 5144127
CAS-51-06-9
CAS-614-39-1
CBDivE_003757
CCG-205075
CHEBI:8428
CHEMBL640
cid_66068
CS-W009100
CTK6E8330
D08421
D0U5SI
DB01035
DivK1c_000931
DR000536
DSSTox_CID_3512
DSSTox_GSID_23512
DSSTox_RID_77059
DTXSID7023512
EINECS 200-078-8
EN300-33971
Epitope ID:135397
F2173-1035
GTPL4811
HMS1361J05
HMS1791J05
HMS1989J05
HMS2089E13
HMS3402J05
HMS553P13
HSDB 3170
IDI1_000931
IDI1_033933
KB-240239
KBio1_000931
KBio2_000183
KBio2_001316
KBio2_002751
KBio2_003884
KBio2_005319
KBio2_006452
KBio3_000365
KBio3_000366
KBio3_001729
KBioGR_000183
KBioGR_000973
KBioSS_000183
KBioSS_001316
KS-00000IJK
L001052
L39WTC366D
Lopac-P-9391
Lopac0_000995
LS-25492
Maybridge1_004389
MCULE-2863739556
MFCD00066880
MolPort-001-783-481
N-(2-Diethylaminoethyl) 4-aminobenzamide
N1-[2-(diethylamino)ethyl]-4-aminobenzamide
NCGC00015859-01
NCGC00015859-02
NCGC00015859-03
NCGC00015859-04
NCGC00015859-05
NCGC00015859-06
NCGC00015859-07
NCGC00015859-08
NCGC00015859-09
NCGC00015859-10
NCGC00015859-11
NCGC00015859-14
NCGC00024323-03
NCGC00024323-04
NCGC00024323-05
NCGC00024323-06
NINDS_000931
Novocainamid
Novocainamide
Novocaine amide
Novocamid
NSC 27461
NSC-27461
NSC27461
p-Amino-N-(2-diethylaminoethyl)benzamide
p-Aminobenzoic diethylaminoethylamide
Prestwick0_000337
Prestwick1_000337
Prestwick2_000337
Prestwick3_000337
Procainamida
Procainamida [INN-Spanish]
PROCAINAMIDE
Procainamide (INN)
Procainamide [INN:BAN]
Procainamidum
Procainamidum [INN-Latin]
Procaine amide
Procamide
Procan
Procan (TN)
Procanbid (TN)
Procapan
Procapan (free base)
Pronestyl
Pronestyl (TN)
Pronestyl-Sr
REQCZEXYDRLIBE-UHFFFAOYSA-N
Rhythmin
SBB005866
SBI-0050968.P004
SCHEMBL15914
SMP1_000055
SPBio_001329
SPBio_002294
Spectrum_000836
Spectrum2_001295
Spectrum3_000555
Spectrum4_000487
Spectrum5_000986
ST077772
ST24043248
STK367963
T7912
Tox21_110246
Tox21_110246_1
UNII-L39WTC366D
WLN: ZR DVM2N2&2
ZINC1530756
ZX-AS003998

US Patents and Regulatory Information for PROCANBID

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms PROCANBID procainamide hydrochloride TABLET, EXTENDED RELEASE;ORAL 020545-002 Jan 31, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
King Pharms PROCANBID procainamide hydrochloride TABLET, EXTENDED RELEASE;ORAL 020545-001 Jan 31, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for PROCANBID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
King Pharms PROCANBID procainamide hydrochloride TABLET, EXTENDED RELEASE;ORAL 020545-002 Jan 31, 1996 ➤ Sign Up ➤ Sign Up
King Pharms PROCANBID procainamide hydrochloride TABLET, EXTENDED RELEASE;ORAL 020545-001 Jan 31, 1996 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Express Scripts
UBS
Colorcon
Johnson and Johnson
Fish and Richardson
Dow
Cipla
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
DrugPatentWatch reviews  
Links

Follow DrugPatentWatch: